|
|
|
MCH |
 |
Phoenix
Pharmaceuticals, Inc.
The Peptide Elite
www.phoenixpeptide.com
|
MCH
MCH (Melanin Concentrating Hormone) and MCH-2 Receptor
Melanin
Concentrating Hormone (MCH) related products
Mice lacking Melanin-Concentrating Hormone are hypophagic and lean.
Shimada, M. et al., Nature 396, 670-673 (1998)
 |
|
 |
| |
 |
4X
|
40X
|
|
Slides courtesy Dr. Nae Dun, James
H. Quillen College of Medicine
East Tennessee State University |
|
|
|
 |
 |
 |
Melanin
Concentrating Hormone (MCH) related products
MELANIN-CONCENTRATING HORMONE RECEPTOR 2 (MCH-2R)
MCHR2 is a G protein-coupled receptor for MCH, a neuropeptide that
plays an important role in the control of feeding behaviors and energy
metabolism.
Melanin-concentrating hormone (MCH) is a cyclic neuropeptide originally
isolated from the salmon pituitary gland. It regulates skin color in teleost
fish in the induction of melanin aggregation in the melanocytes. Mammalian
MCH is present in neurons of both the central and peripheral nervous systems,
with predominant expression in the lateral hypothalamus and zona incerta.
Its central role is in the control of feeding behaviors and energy metabolism.
When administered centrally, MCH promotes food intake. Its expression
in the lateral hypothalamus is induced by starvation. MCH knockout mice
are lean and hypophagic and have increased metabolic rates and reduced
body weight. Overexpression of MCH in transgenic mice leads to obesity.
MCH and components of MCH signaling pathways are therefore very attractive
as potential antiobesity drug targets. An and co-workers. (2001) identified MCHR2
by searching human genomic sequences with a GPCR (G protein-coupled receptor)
hidden Markov model. They found that MCHR2 is most similar to MCHR1, with
36% amino acid identity overall and 44% amino acid identity in the transmembrane
regions. The expression of MCHR2 was detected in most regions of the brain
examined by RNA dot array hybridization. While MCHR1 is intronless in
the coding region, the MCHR2 gene has 5 coding and 1 noncoding exon. MCHR2
is specifically activated by nanomolar concentrations of MCH, binds to
MCH with high affinity, and signals through Gq protein.
Sailer and co-workers. (2001) simultaneously reported the identification of MCHR2
and likewise showed that it shares about 38% amino acid identity with
MCHR1. They found that in contrast to MCHR1, MCHR2 signaling was not sensitive
to pertussis toxin and MCHR2 cannot reduce forskolin-stimulated cAMP production,
suggesting an exclusive G-alpha-q coupling of the MCHR2 in cell-based
systems. By Northern blot and in situ hybridization analysis of human
and monkey tissue, Sailer and co-workers (2001) showed that expression of MCHR2
mRNA is restricted to several regions of the brain, including the arcuate
nucleus and the ventral medial hypothalamus, areas implicated in regulation
of body weight.
Holder and co-workers (2000) described an obese girl with a balanced translocation
involving the region of chromosome 6 where the MCHR2 resides; they demonstrated
disruption of the SIM1 gene located at 6q16.2. Sailer and co-workers (2001) estimated
that the SIM1 and MCHR2 genes are located within 1 Mb of each other. As
reviewed by Gilhuis and co-workers (2000), 4 other obese patients with cytogenetic
alterations in the same region of 6q had been reported; all had in common
some clinical features, including obesity, hypotonia, and developmental
delays, resembling Prader-Willi syndrome (PWS). However, their behavior,
facial features, and additional neurologic abnormalities, as well as a
lack of cytogenetic changes or imprinting mutations on chromosome 15,
clearly distinguished this PWS-like phenotype from PWS patients.
MCH-2R Antibody for Immunohistochemistry
|
|
|
|
| MCH-R2
Immunohistochemistry |
| Tissue
Sample |
Rat
brain |
| Fixative |
10%
formalin |
| Embedding |
paraffin |
| Negative
Control |
No
primary antibody |
| Pretreatment |
Target
retrieval 25 min (Steam) |
| Blocking |
2%
Normal Goat Serum |
| Primary
Antibody |
Anti-MCH-R2
(237-259), Cys0,(Human) Antibody (Catalog No.: H-071-20) |
| Optimal
Dilution |
1:100 |
| Secondary
Antibody |
Goat
Anti-Rabbit IgG, Biotinylated (1:400) |
| Amplification |
ABC
(Vector) |
| Detection
System |
HRP |
| Substrate |
DAB
(Sigma) |
| Counterstained |
Hematoxylin |
|
|
|
New Anti-MCH-2R (237-251), Cys0,(Human) Antibody
Detection of MCH-2R with dot blot analysis
|
 |
References:
- Sailer, A. W.; Sano, H.; Zeng, Z.; McDonald, T. P.; Pan, J.;
Pong, S.-S.; Feighner, S. D.; Tan, C. P.; Fukami, T.; Iwaasa,
H.; Hreniuk, D. L.; Morin, N. R.; and 15 others : Identification
and characterization of a second melanin-concentrating hormone
receptor, MCH-2R. Proc. Nat. Acad. Sci. 98: 7564-7569, 2001.
- An, S.; Cutler, G.; Zhao, J. J.; Huang, S.-G.; Tian, H.; Li,
W.; Liang, L.; Rich, M.; Bakleh, A.; Du, J.; Chen, J.-L.; Dai,
K. : Identification and characterization of a melanin-concentrating
hormone receptor. Proc. Nat. Acad. Sci. 98: 7576-7581, 2001.
- Hill, J.; Duckworth, M.; Murdock, P.; Rennie, G.; Sabido-David,
C.; Ames, R. S.; Szekeres, P.; Wilson, S.; Bergsma, D. J.; Gloger,
I. S.; Levy, D. S.; Chambers, J. K.; Muir, A. I. : Molecular cloning
and functional characterization of MCH-2, a novel human MCH receptor.
J. Biol. Chem. 276: 20125-20129, 2001.
- Mori, M.; Harada, M.; Terao, Y.; Sugo, T.; Watanabe, T.; Shimomura,
Y.; Abe, M.; Shintani, Y.; Onda, H.; Nishimura, O.; Fujino, M.
: Cloning of a novel G protein-coupled receptor, SLT, a subtype
of the melanin-concentrating hormone receptor. Biochem. Biophys.
Res. Commun. 283: 1013-1018, 2001.
- Holder, J. L.; Jr.; Butte, N. F.; Zinn, A. R. : Profound obesity
associated with a balanced translocation that disrupts the SIM1
gene. Hum. Molec. Genet. 9: 101-108, 2000.
- Gilhuis, H. J.; van Ravenswaaij, C. M.; Hamel, B. J. C.; Gabreels,
F. J. M. : Interstitial 6q deletion with a Prader-Willi-like phenotype:
a new case and review of the literature. Europ. J. Paediat. Neurol.
4: 39-43, 2000.
- McKusick, V. A. et al.OMIM:*606111
|
Amino Acid
Sequence of MCH-R2 (Human)
1 mnpfhascwn tsaellnksw nkefayqtas vvdtvilpsm igiicstglv
gnilivftii
61 rsrkktvpdi yicnlavadl vhivgmpfli hqwarggewv fggplctiit
sldtcnqfac
121 saimtvmsvd ryfalvqpfr ltrwrtrykt irinlglwaa sfilalpvwv
yskvikfkdg
181 vescafdlts pddvlwytly ltittfffpl plilvcyili lcytwemyqq
nkdarccnps
241 vpkqrvmklt
kmvlvlvvvf ilsaapyhvi qlvnlqmeqp tlafyvgyyl siclsyasss
301 inpflyills gnfqkrlpqi qrratekein nmgntlkshf
|
 |
 |
 |
| |
| Product Name |
Code |
Quantity |
Price |
| MCH-R2 (237-251) , Cys0,(Human)
Antibody |
H-071-20 |
50ul |
$450 |
| MCH-R2 (237-251), Cys0, (Human)
Purified IgG |
G-071-20 |
200ug |
$450 |
| MCH-R2 (237-251) , Cys0,(Human)
Purified IgG FAM labeled |
FG-G-071-20 |
100ul |
$500 |
| MCH-R2 (237-251) , Cys0,
(Human) Purified IgG Rhodamine labeled |
FR-G-071-20 |
100ul |
$500 |
| MCH-R2 (237-251) , Cys0,
(Human) Purified IgG Biotin labeled |
B-G-071-20 |
100ul |
$500 |
| MCH-R2 (237-251) (Human) Dot Blot Kit |
DBK-071-20 |
kit |
$650 |
| MCH-R2 (237-251) (Human) |
071-20 |
100ug |
$140 |
|
|
 |
 |
 |
 |
| Comparison of half-maximal
concentrations for binding at and functional activation
of human MCH-1R and MCH-2R by MCH, Phe13Tyr19-MCH,
and salmon MCH
|
| |
| Ligand |
Binding IC50, nM ± SEM
(n) |
Function EC50, nM ± SEM
(n) |
| MCH-1R |
MCH-2R |
MCH-1R |
MCH-2R |
| |
| MCH |
0.3 ± 0.1 (10) |
1.5 ± 0.9 (8) |
3.9 ± 1.2 (3) |
0.1 ± 0.1 (3) |
| Phe13Tyr19-MCH |
0.3 ± 0.1 (3) |
0.8 ± 0.1 (3) |
8.5 ± 0.9 (3) |
0.2 ± 0.1 (3) |
| Salmon MCH |
0.2 ± 0.1 (5) |
436.7 ± 143.8 (3) |
35.0 ± 14.8 (3) |
0.8 ± 0.1 (3) |
| |
| Membrane binding was assessed by
competition of [125I]Phe13Tyr19-MCH
in a scintillation proximity assay. Functional
activation was measured by mobilization of intracellular
calcium detected in a fluorometric imaging plate
reader assay. Values shown are nanomolar concentrations
and averaged from at least three independent experiments. |
|
| Fig. (A)
Agonist-induced calcium mobilization in a CHO cell line
stably expressing human MCH-2R as detected by a fluorometric
imaging plate reader (FLIPR) assay. MCH, Phe13Tyr19-MCH
, salmon MCH;(B) Membrane binding assay using
a scintillation proximity assay measuring specific binding
of [125I]Phe13Tyr19-MCH
to MCH-2R containing membranes. (C and D)
PTX sensitivity of intracellular calcium mobilization
mediated by MCH-1R (C) or MCH-2R (D) in
HEK293-AEQ17 cell lines. Stable transfected HEK293-AEQ17
cell lines were treated with 0 ng/ml (circles),
150 ng/ml (triangles), 500 ng/ml (diamonds),
or 5,000 ng/ml (rectangles) PTX before the aequorin
assay.
Sailer AW, et al. Identification and characterization
of a second melanin-concentrating hormone receptor,
MCH-2R. Proc Natl Acad Sci U S A 2001 Jun 19;98(13):7564-9
|
|
|
MCH Receptor Ligand, SLC-1 (Rat) Orphan Receptor Fragments and
Related Peptides
Recently, two groups have identified a 353 amino acid G-coupled
orphan receptor as receptor for MCH: Chambers, J. et al., Nature
400, 261-265 (1999) and Saito, Y. et al., Nature 400, 265-269
(1999). We offer several rat SLC-1 receptor fragments for antibody
production as well as MCH and related peptides for obesity research
and other studies.
Melanin
Concentrating Hormone (MCH) related products
©2003-2004CO¿µëÄÉúÎï¿Æ¼¼(±±¾©)ÓÐÏÞ¹«Ë¾
|
|